Journal of Clinical and Cellular Immunology

Journal of Clinical and Cellular Immunology
Open Access

ISSN: 2155-9899

+44 1223 790975

Association of pro-inflammatory cytokines with breast cancer risk factors


2nd International Conference on Clinical & Cellular Immunology

October 15-17, 2013 Hampton Inn Tropicana, Las Vegas, NV, USA

Hanna Mirette

Accepted Abstracts: J Clin Cell Immunol

Abstract :

Pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) seem to play a role in breast cancer development. We examined the association of IL-6 and TNF-α protein expression levels in normal breast epithelium with two breast cancer risk factors; mammographic density (MD) and lobular involution. Tissue microarray (TMA) blocks were constructed from normal breast tissue extracted from mastectomy blocks of 20 breast cancer patients aged 50-65 years. The IL-6 and TNF-α epithelial intensity of staining (none, weak, moderate or high) was visually assessed on immunohistochemically stained TMA sections. MD was visually assessed (<25%, 25-49% or ≥50%) on digitized mammographic images. The degree of lobular involution (none, partial or complete) and the dominant lobular type (type 1, 2 or 3) were evaluated on hematoxylin and eosin stained slides containing normal breast tissue. IL-6 epithelial intensity of staining was positively correlated with MD after adjustment for age and body mass index (r=0.49; p =0.04). There was a non-significant correlation between TNF-α epithelial intensity of staining and the dominant lobular type after adjustment for parity (r=0.43; p =0.06). Increased IL-6 expression in normal breast tissue might be associated with increased MD. Modifying pro-inflammatory cytokines expression in normal breast tissue might be a promising tool to affect MD and consequently breast cancer risk.

Biography :

Mirette Hanna has completed her bachelor degree of medicine from Alexandria University Faculty of Medicine, Blood bank and Clinical Pathology residency from Ministry of health and a Master Degree of Clinical and Chemical Pathology from Ain-Shams University Faculty of Medicine. She is a Ph.D. candidate in experimental medicine program at Laval University Faculty of Medicine.

Top